LEVOCETIRIZINE , PHENLEPHIRNE & AMBROXOL

Aug 26, 2023

STERIMMUNE COLD
Levocetirizine, Phenylephirne & Ambroxol
Certainly, here's information about the three substances you've mentioned: Levocetirizine, Phenylephrine, and Ambroxol.

Levocetirizine:
Levocetirizine is an antihistamine commonly used to relieve allergy symptoms. It is the active enantiomer of cetirizine and is used to treat conditions such as hay fever, allergic rhinitis, and chronic idiopathic urticaria (hives without a known cause). Levocetirizine works by blocking the effects of histamine, a substance produced by the body during allergic reactions that can cause symptoms like itching, sneezing, runny nose, and watery eyes. It is available in various forms, including oral tablets and syrups.

Phenylephrine:
Phenylephrine is a decongestant that works by narrowing blood vessels. It is commonly used to relieve nasal congestion caused by allergies, colds, or sinus infections. By constricting blood vessels in the nasal passages, phenylephrine reduces swelling and congestion, making it easier to breathe. It can be found in various over-the-counter oral medications, nasal sprays, and eye drops.

Ambroxol:
Ambroxol is an expectorant and mucolytic agent often used to treat respiratory conditions involving excessive mucus production, such as coughs associated with colds, bronchitis, and other respiratory infections. Ambroxol works by thinning and loosening mucus, making it easier to cough up and clear from the airways. This can help alleviate congestion and improve breathing. It is available in various forms, including oral tablets, syrups, and inhalation solutions.

As with any medications or substances, it's important to use them according to the recommended dosage and guidelines provided by a healthcare professional or as indicated on the packaging. If you have any underlying medical conditions or are taking other medications, it's advised to consult with a healthcare provider before using these substances to ensure they are safe and appropriate for your situation.
For further information please contact:
contact@sterispharma.com

SHARE WITH